Fed. Circ. Pauses Ouster Of Teva Patents From Orange Book

By Bryan Koenig · July 11, 2024, 7:02 PM EDT

Teva can keep challenged asthma inhaler device patents listed on, and protected by, an important government database after the Federal Circuit agreed Wednesday to pump the brakes on the patents' delisting...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login